The role of IL-10 within the tumor milieu remains uncertain; nonetheless, studies indicate that both VEGF and IL-10 levels are elevated in multiple myeloma relative to healthy individuals and rise concurrently with the ISS stage [12,17]. This evidence concerns the gene IL10 and AL amyloidosis.